StockData
Microbot Medical Inc. logo

Microbot Medical Inc. (MBOT) stock

MBOTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.98−0.05 (-4.98%)

Close on Nov 13, 2026Market cap $65.73MP/E –Yield –

Microbot Medical gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2013 it was 514.6%, against 80.8% the year before. The highest annual figure on record is 514.6% in fiscal 2013.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2013Dec 31, 2013514.6%+433.8
FY2012Dec 31, 201280.8%−1.6
FY2011Dec 31, 201182.4%−5.8
FY2010Dec 31, 201088.2%+14.5
FY2009Dec 31, 200973.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-1420.8%–
Q2 FY2026Jun 30, 2026-266.8%–
Q1 FY2026Mar 31, 20261.9%–

More Microbot Medical figures

See a number that looks wrong?